About Granules India Ltd
Granules India is a vertically integrated pharmaceutical manufacturing company. it specializes in Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), distributing to over 80 countries.
Founded
1991
CEO
C Krishna Prasad
Employees
6,523
HQ
Hyderabad, India
Finished Products
1Sale of Products
₹10,099.56Cr2Other Operating Revenue
₹159.66CrRaw Materials
1Raw Material Consumed
₹4,806.29CrAbout Granules India Ltd
Granules India is a vertically integrated pharmaceutical manufacturing company. it specializes in Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), distributing to over 80 countries.
Founded:1991
CEO:C Krishna Prasad
Employees:6,523
HQ:Hyderabad, India
Finished Products
1Sale of Products
₹10,099.56Cr2Other Operating Revenue
₹159.66CrRaw Materials
1Raw Material Consumed
₹4,806.29CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹910
52W Low
₹504
Volume787.51K
Avg VolumeN/A
Beta0.86
Dividend Yield0.21%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
31.10x
Valuation
P/B Ratio
4.36x
Valuation
EPS
₹26.73
Valuation
Dividend Yield
0.21%
Valuation
ROE
11.70%
Profitability
ROCE
13.63%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical products including iRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
4.1%
International
95.9%
Outside India95.9%
Within India4.1%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.30x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
6.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.